Publication date: September 2026 Source: The Lancet Healthy Longevity, Volume 7, Issue 9 Author(s): Anne Marie Reimer Jensen, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, Negar Aliabadi, Kristoffer G Skaarup, Daniel Modin, Kira Hyldekær Janstrup, Brian L Claggett, Carsten S Larsen, Lykke Larsen, Lothar Wiese, Michael Dalager-Pedersen, Matias G Lindholm, Maria Dons, Katrine F Bernholm, Filip S Davidovski, Lisa S Duus, Camilla I Ottosen, Anne B Nielsen
RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial. // The Lancet Healthy Longevity. – URL: https://www.sciencedirect.com/science/article/pii/S2666756826000796?dgcid=rss_sd_all
RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial. The Lancet Healthy Longevity. https://www.sciencedirect.com/science/article/pii/S2666756826000796?dgcid=rss_sd_all
“RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial.” The Lancet Healthy Longevity.
@article{article90929,
title = {RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial},
journal = {The Lancet Healthy Longevity},
url = {https://www.sciencedirect.com/science/article/pii/S2666756826000796?dgcid=rss_sd_all}
}